Personalized treatments are increasingly preferred when facing many diseases and conditions. Such treatments depend on finding and interpreting individual genetic information. However, this information is often complex and can overwhelm conventional data systems.
Pangenia’s advanced test platforms can rapidly process huge amounts of genetic information within a shorter time. Our analytical instruments utilize next-generation sequencing (NGS) technology which can meticulously screen sections of an individual’s genome to identify mutations. This can be hugely effective in designing personalized treatments. We also provide real-time PCR and Sanger sequencing test services to meet patients’ differing needs.
Next-generation sequencing (NGS)
NGS technology targets genes and mutations relevant to particular cancers. With significantly higher read length and read depth than traditional techniques, NGS allows us to sequence large genomic regions, providing comprehensive genetic profiles in a single efficient and cost-effective report. This form of testing helps identify rare somatic mutations which may have been misinterpreted as negative.
Real-time PCR testing allows us to analyze multiple targets simultaneously within a single reaction. This has a number of advantages, and can provide internal controls, lower reagent costs and preserve precious samples. Real-time PCR testing can provide reports in three to five days.